- Treatment of Acute Myeloid Leukemia with 20-30% blasts in patients who are not eligible for Haemopoietic stem cell transplant
- Intermediate-2 and High-risk Myelodysplastic syndrome (MDS)
AZACYTIN
MRP | : |
|
Price | : | ₹1,410.00 |
You Save | : | ₹4,351.17 (75.53%) |
1 vial(s)
Azacytin 100mg Injection is specifically used for treating adults diagnosed with Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML), particularly if they are considered ineligible for a stem cell transplant. In Myelodysplastic Syndrome, the bone marrow unfortunately does not produce healthy blood cells due to its impaired function. Acute Myeloid Leukemia, on the other hand, is a severe type of bone marrow cancer that is characterized by the release of incompletely formed blood cells into the bloodstream.